|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 39 of 49 found articles
| Title: |
Prexasertib, a cell cycle checkpoint kinase 1 and 2 inhibitor, in BRCA wild-type recurrent high-grade serous ovarian cancer: a first-in-class proof-of-concept phase 2 study |
| Author: |
Lee, Jung-Min Nair, Jayakumar Zimmer, Alexandra Lipkowitz, Stanley Annunziata, Christina M Merino, Maria J Swisher, Elizabeth M Harrell, Maria I Trepel, Jane B Lee, Min-Jung Bagheri, Mohammad H Botesteanu, Dana-Adriana Steinberg, Seth M Minasian, Lori Ekwede, Irene Kohn, Elise C |
| Appeared in: |
Lancet oncology |
| Paging: | Volume 19 (2018) nr. 2 pages 207-215 |
| Year: |
2018 |
| Contents: | |
| Publisher: |
Elsevier Ltd |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 39 of 49 found articles
| << previous | next >> |